Dezhan Healthcare Company Limited (000813.SZ)

CNY 3.02

(-1.95%)

Revenue Summary of Dezhan Healthcare Company Limited

  • Dezhan Healthcare Company Limited's latest annual revenue in 2023 was 498.08 Million CNY , down -12.75% from previous year.
  • Dezhan Healthcare Company Limited's latest quarterly revenue in 2024 Q1 was 98.16 Million CNY , down -39.75% from previous quarter.
  • Dezhan Healthcare Company Limited reported a annual revenue of 570.85 Million CNY in annual revenue 2022, down -22.28% from previous year.
  • Dezhan Healthcare Company Limited reported a annual revenue of 734.47 Million CNY in annual revenue 2021, down -23.72% from previous year.
  • Dezhan Healthcare Company Limited reported a quarterly revenue of 103.71 Million CNY for 2024 Q3, down -26.41% from previous quarter.
  • Dezhan Healthcare Company Limited reported a quarterly revenue of 144.24 Million CNY for 2024 Q2, up 46.94% from previous quarter.

Annual Revenue Chart of Dezhan Healthcare Company Limited (2023 - 1995)

Historical Annual Revenue of Dezhan Healthcare Company Limited (2023 - 1995)

Year Revenue Revenue Growth
2023 498.08 Million CNY -12.75%
2022 570.85 Million CNY -22.28%
2021 734.47 Million CNY -23.72%
2020 962.86 Million CNY -45.75%
2019 1.77 Billion CNY -46.06%
2018 3.29 Billion CNY 48.22%
2017 2.22 Billion CNY 53.87%
2016 1.44 Billion CNY 182.51%
2015 510.77 Million CNY -8.69%
2014 559.37 Million CNY -1.72%
2013 569.17 Million CNY 121.21%
2012 257.3 Million CNY -14.45%
2011 300.75 Million CNY 1.39%
2010 296.63 Million CNY 19.19%
2009 248.87 Million CNY -34.71%
2008 381.21 Million CNY 12.76%
2007 338.08 Million CNY 8.72%
2006 310.95 Million CNY -13.16%
2005 358.07 Million CNY 5.74%
2004 338.62 Million CNY -10.69%
2003 379.16 Million CNY 1.9%
2002 372.09 Million CNY 27.41%
2001 292.03 Million CNY -36.97%
2000 463.35 Million CNY -0.7%
1999 466.63 Million CNY -0.25%
1998 467.8 Million CNY 13.3%
1997 412.89 Million CNY 11.94%
1996 368.86 Million CNY 18.57%
1995 311.09 Million CNY 0.0%

Peer Revenue Comparison of Dezhan Healthcare Company Limited

Name Revenue Revenue Difference
Shenzhen Neptunus Bioengineering Co., Ltd. 36.41 Billion CNY 98.632%
Anhui Fengyuan Pharmaceutical Co., Ltd. 4.27 Billion CNY 88.35%
Dong-E-E-Jiao Co.,Ltd. 4.71 Billion CNY 89.437%
Livzon Pharmaceutical Group Inc. 12.27 Billion CNY 95.943%
Hainan Haiyao Co., Ltd. 1.45 Billion CNY 65.819%
Tus-Pharmaceutical Group Co., Ltd. 395.92 Million CNY -25.804%
Jilin Aodong Pharmaceutical Group Co., Ltd. 3.44 Billion CNY 85.559%
Changchun High-Tech Industries (Group) Inc. 14.46 Billion CNY 96.555%
Apeloa Pharmaceutical Co.,Ltd 11.47 Billion CNY 95.659%
PKU HealthCare Corp.,Ltd. 2.19 Billion CNY 77.296%
Chengdu Huasun Technology Group Inc., Ltd. 1 Billion CNY 50.359%
Jinling Pharmaceutical Company Limited 2.78 Billion CNY 82.12%
Jiuzhitang Co., Ltd. 2.91 Billion CNY 82.938%
Huapont Life Sciences Co., Ltd. 11.59 Billion CNY 95.704%
Zhejiang Jingxin Pharmaceutical Co., Ltd. 3.95 Billion CNY 87.397%
Shandong Wohua Pharmaceutical Co., Ltd. 894.31 Million CNY 44.305%
Hengkang Medical Group Co., Ltd. 3.59 Billion CNY 86.128%
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 2.61 Billion CNY 80.92%
Qianjiang Yongan Pharmaceutical Co., Ltd. 962.8 Million CNY 48.267%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 5.42 Billion CNY 90.813%
Jinhe Biotechnology CO., LTD. 2.17 Billion CNY 77.09%
Teyi Pharmaceutical Group Co.,Ltd 1.06 Billion CNY 53.328%
Kunming Longjin Pharmaceutical Co., Ltd. 86.62 Million CNY -475.01%
Beijing Aosaikang Pharmaceutical Co., Ltd. 1.44 Billion CNY 65.493%
Chengdu Kanghong Pharmaceutical Group Co., Ltd 3.95 Billion CNY 87.414%
Anhui Huangshan Capsule Co., Ltd. 458.36 Million CNY -8.665%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd 980.82 Million CNY 49.218%
Zhuhai Rundu Pharmaceutical Co., Ltd. 1.29 Billion CNY 61.445%
Huaren Pharmaceutical Co., Ltd. 1.63 Billion CNY 69.559%
Tianjin Ringpu Bio-Technology Co.,Ltd. 2.24 Billion CNY 77.853%
Shanxi Zhendong Pharmaceutical Co.,Ltd 3.62 Billion CNY 86.263%
Fuan Pharmaceutical (Group) Co., Ltd. 2.64 Billion CNY 81.188%
Hybio Pharmaceutical Co., Ltd. 431.38 Million CNY -15.463%
Baotou Dongbao Bio-Tech Co.,Ltd 974.51 Million CNY 48.888%
Hunan Er-Kang Pharmaceutical Co., Ltd 1.76 Billion CNY 71.847%
Changjiang Pharmaceutical Group Co., Ltd. 1.19 Billion CNY 58.408%
Zhejiang Garden Bio-chemical High-tech Co., Ltd. 1.09 Billion CNY 54.498%
Fujian Cosunter Pharmaceutical Co., Ltd. 422.71 Million CNY -17.831%
Beijing Science Sun Pharmaceutical Co., Ltd. 476.56 Million CNY -4.515%
Zhejiang Xinguang Pharmaceutical Co., Ltd. 270.39 Million CNY -84.204%
Hainan Poly Pharm. Co., Ltd 1.3 Billion CNY 61.817%
Jiangxi Synergy Pharmaceutical Co., Ltd. 722.13 Million CNY 31.026%
Wuhan Hiteck Biological Pharma Co.,Ltd 602.28 Million CNY 17.3%
Shandong Xinhua Pharmaceutical Company Limited 8 Billion CNY 93.781%
Zhejiang Tianyu Pharmaceutical Co., Ltd. 2.52 Billion CNY 80.291%
PharmaBlock Sciences (Nanjing), Inc. 1.72 Billion CNY 71.129%
Jinghua Pharmaceutical Group Co., Ltd. 1.49 Billion CNY 66.581%
Zhejiang Hisoar Pharmaceutical Co., Ltd. 2.17 Billion CNY 77.067%
Betta Pharmaceuticals Co., Ltd. 2.45 Billion CNY 79.721%
Tibet AIM Pharm. Inc. 667.03 Million CNY 25.328%
Shenzhen Kangtai Biological Products Co., Ltd. 3.47 Billion CNY 85.677%
Shandong Shanda Wit Science and Technology Co., Ltd. 2.48 Billion CNY 79.949%
Pacific Shuanglin Bio-pharmacy Co., LTD 2.32 Billion CNY 78.611%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. 1.62 Billion CNY 69.365%
Xiamen Kingdomway Group Company 3.1 Billion CNY 83.946%
ShanXi C&Y Pharmaceutical Group Co., Ltd. 799.3 Million CNY 37.685%
Walvax Biotechnology Co., Ltd. 4.11 Billion CNY 87.892%
Sunflower Pharmaceutical Group Co.,Ltd 5.63 Billion CNY 91.156%
Harbin Gloria Pharmaceuticals Co., Ltd 2.58 Billion CNY 80.768%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 24.73 Billion CNY 97.987%
Hunan Hansen Pharmaceutical Co., Ltd. 955.53 Million CNY 47.873%
Changzhou Qianhong Biopharma CO.,LTD 1.79 Billion CNY 72.234%
Shenzhen Weiguang Biological Products Co., Ltd. 1.04 Billion CNY 52.495%
Honz Pharmaceutical Co., Ltd. 739.56 Million CNY 32.652%
Northeast Pharmaceutical Group Co., Ltd. 8.16 Billion CNY 93.897%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd 1.46 Billion CNY 65.947%
Guizhou Xinbang Pharmaceutical Co., Ltd. 6.46 Billion CNY 92.291%
Tianjin Lisheng Pharmaceutical Co.,Ltd. 1.13 Billion CNY 55.928%
Zhejiang Yatai Pharmaceutical Co., Ltd. 420.64 Million CNY -18.411%
Zhejiang NHU Company Ltd. 15.11 Billion CNY 96.705%
ApicHope Pharmaceutical Co., Ltd 2.5 Billion CNY 80.104%
Shanghai Kaibao Pharmaceutical CO.,Ltd 1.59 Billion CNY 68.753%
Beijing SL Pharmaceutical Co., Ltd. 1.01 Billion CNY 51.089%
Yunnan Baiyao Group Co.,Ltd 38.9 Billion CNY 98.72%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD 1.08 Billion CNY 53.883%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. 839.25 Million CNY 40.651%
Guangdong Lifestrong Pharmacy Co., Ltd. 292.39 Million CNY -70.346%
Huadong Medicine Co., Ltd 40.39 Billion CNY 98.767%
Jiangsu Nhwa Pharmaceutical Co., LTD 4.97 Billion CNY 89.985%
Harbin Medisan Pharmaceutical Co., Ltd. 1.18 Billion CNY 58.03%
LanZhou Foci Pharmaceutical Co.,Ltd. 1.16 Billion CNY 57.177%
Tianjin Chase Sun Pharmaceutical Co.,Ltd 6.12 Billion CNY 91.871%
Beijing Beilu Pharmaceutical Co., Ltd 890.71 Million CNY 44.08%
Nanjing Hicin Pharmaceutical Co., Ltd. 517.83 Million CNY 3.813%
Renhe Pharmacy Co., Ltd. 5.03 Billion CNY 90.102%
Chongqing Pharscin Pharmaceutical Co., Ltd. 691.54 Million CNY 27.974%
Zhejiang Xianju Pharmaceutical Co.,Ltd. 4.12 Billion CNY 87.921%
Luoxin Pharmaceuticals Group Stock Co., Ltd. 2.34 Billion CNY 78.738%
Guizhou Bailing Group Pharmaceutical Co., Ltd. 4.26 Billion CNY 88.316%